Skip to main content

. 1983 Apr 2;286(6371):1106. doi: 10.1136/bmj.286.6371.1106

Angiotensin converting enzyme: a tumour marker in malignant histiocytosis.

F Boomsma, J J Michiels, E Prins, J Abels, M A Schalekamp

PMCID: PMC1547502 PMID: 6301612

1106

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Borowsky S. A., Lieberman J., Strome S., Sastre A. Elevation of serum angiotensin-converting enzyme level. Occurrence in alcoholic liver disease. Arch Intern Med. 1982 May;142(5):893–895. [PubMed] [Google Scholar]
Groopman J. E., Golde D. W. The histiocytic disorders: a pathophysiologic analysis. Ann Intern Med. 1981 Jan;94(1):95–107. doi: 10.7326/0003-4819-94-1-95. [DOI] [PubMed] [Google Scholar]
Rømer F. K., Emmertsen K. Serum angiotensin-converting enzyme in malignant lymphomas, leukaemia and multiple myeloma. Br J Cancer. 1980 Aug;42(2):314–318. doi: 10.1038/bjc.1980.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
Yotsumoto H., Imai Y., Kuzuya N., Uchimura H., Matsuzaki F. Increased levels of serum angiotensin-converting enzyme activity in hyperthyroidism. Ann Intern Med. 1982 Mar;96(3):326–328. doi: 10.7326/0003-4819-96-3-326. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES